APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases

A patient with the PSEN1 E280A mutation and homozygous for APOE3 Christchurch (APOE3Ch) displayed extreme resistance to Alzheimer’s disease (AD) cognitive decline and tauopathy, despite having a high amyloid burden. To further investigate the differences in biological processes attributed to APOE3Ch...

Description complète

Détails bibliographiques

Auteurs principaux:	Paula Perez-Corredor, Timothy E. Vanderleest, Guido N. Vacano, Justin S. Sanchez, Nelson D. Villalba-Moreno, Claudia Marino, Susanne Krasemann, Miguel A. Mendivil-Perez, David Aguillón, Marlene Jiménez-Del-Río, Ana Baena, Diego Sepulveda-Falla, Francisco Lopera, Yakeel T. Quiroz, Joseph F. Arboleda-Velasquez, Randall C. Mazzarino
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2024-03-01
Collection:	Frontiers in Molecular Neuroscience
Sujets:	Wnt signaling ApoE iPS cells CRISPR Alzheimer’s disease ApoE Christchurch
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fnmol.2024.1373568/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!